radionuclide therapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Jules Bordet Institute (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadbone marrow procedure

I am/have/hadfdg pet/ct

I am/have/hadfdg-pet

I am/have/hadrefractory multiple myeloma

I am/have/hadpet/ct scan

I am/have/hadmultiple myeloma

I am/have/hadrenal function

I am/have/hadmeasurable disease

added new label for I am/have/had

more

I am looking for

I am looking forbortezomib

I am looking fordaratumumab

I am looking forcarfilzomib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

This study wil assess somatostatin receptor (SSTR) expression via the uptake of Gallium-68 labelled DOTA-conjugated SSTR targeting peptide using PET/CT imaging in multiple myeloma lesions pre-identified on 18F-FDG PET/CT in order to evaluate the feasibility of molecular radionuclide therapy in refractory and relapsing mutiple myeloma using the Lutetium-177 radiolabelled targeting …

bone marrow procedure

bortezomib

fdg pet/ct

fdg-pet

refractory multiple myeloma

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.